The earnings call conveyed a generally positive sentiment, with significant revenue and adjusted EBITDA growth across most business segments and an upward revision of the financial outlook for 2025. However, some challenges were noted, including a revenue decline in Nelson Labs and a margin decrease for Nordion. The impact of a legal settlement also affected net income.

Company Guidance -

Q3 2025

During Sotera Health's second quarter 2025 earnings call, the company reported strong financial performance and provided updated guidance for the rest of the year. Sotera Health achieved a 6.4% increase in revenue, reaching $294 million, and a 9.8% growth in adjusted EBITDA to $151 million. Adjusted EBITDA margins improved by 156 basis points to 51.2%. The company's Sterigenics segment saw a 10.5% increase in revenue, driven by a 6% rise in volume and mix and a 4% pricing uptick. Nordion's revenue increased by 2.9%, while Nelson Labs experienced a 3.3% revenue decline but improved margins by 514 basis points due to core lab testing and optimization. The company's net leverage ratio improved to 3.5x, and they raised their full-year 2025 guidance, projecting revenue growth of 4.5% to 6% and adjusted EBITDA growth of 6% to 7.5%. Adjusted EPS guidance was increased to a range of $0.75 to $0.82. The company also reported positive operating cash flow of $57 million and capital expenditures totaling $31 million for the quarter.

Strong Top Line and Adjusted EBITDA Growth

Sotera Health delivered a 6.4% increase in revenue and a 9.8% growth in adjusted EBITDA for Q2 2025 compared to Q2 2024.

Sterigenics Revenue Surge

Sterigenics achieved a 10.5% year-over-year revenue growth driven by increased customer demand and successful facility expansion.

Nordion's Strong Performance

Nordion exceeded revenue expectations with a 2.9% increase in Q2 2025, attributed to the timing of Cobalt-60 shipments.

Nelson Labs Margin Expansion

Nelson Labs saw a segment income margin expansion of over 500 basis points, marking the fourth consecutive quarter of improvement.

Raised 2025 Financial Outlook

Sotera Health increased its 2025 revenue growth outlook to 4.5%-6% and adjusted EBITDA growth outlook to 6%-7.5%.

Strong Liquidity Position

Sotera Health ended Q2 with $918 million in available liquidity, including $332 million in unrestricted cash.

Sotera Health (SHC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

SHC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	0.22 / -	0.17	―	―	―
Aug 08, 2025	2025 (Q2)	0.17 / 0.20	0.19	5.26% (+0.01)
May 01, 2025	2025 (Q1)	0.12 / 0.14	0.13	7.69% (+0.01)
Feb 27, 2025	2024 (Q4)	0.20 / 0.21	0.26	-19.23% (-0.05)
Nov 05, 2024	2024 (Q3)	0.18 / 0.17	0.21	-19.05% (-0.04)
Aug 05, 2024	2024 (Q2)	0.17 / 0.19	0.21	-9.52% (-0.02)
May 02, 2024	2024 (Q1)	0.12 / 0.13	0.13	0.00% (0.00)
Feb 27, 2024	2023 (Q4)	0.26 / 0.26	0.25	4.00% (+0.01)
Nov 01, 2023	2023 (Q3)	0.20 / 0.21	0.23	-8.70% (-0.02)
Aug 03, 2023	2023 (Q2)	0.18 / 0.21	0.27	-22.22% (-0.06)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

SHC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 08, 2025	$11.22	$13.97	+24.51%
May 01, 2025	$11.50	$12.10	+5.22%
Feb 27, 2025	$13.64	$12.28	-9.97%
Nov 05, 2024	$15.80	$15.42	-2.41%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sotera Health (SHC) report earnings?

Sotera Health (SHC) is schdueled to report earning on Nov 05, 2025, Before Open (Confirmed).

What is Sotera Health (SHC) earnings time?

Sotera Health (SHC) earnings time is at Nov 05, 2025, Before Open (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is SHC EPS forecast?

SHC EPS forecast for the fiscal quarter 2025 (Q3) is 0.22.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing